USA
Meldepflichtige Eigengeschäfte von Führungskräften (Directors' Dealings) gemäß Art. 19 MAR – wer im eigenen Unternehmen kauft und verkauft.
Datenstand: 23.10.2026
| Gemeldet ↓ | Geschäft | Unternehmen | Insider | Position | Art | Volumen |
|---|---|---|---|---|---|---|
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 55.094,10 USD |
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 219.327,60 USD |
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 345.059,00 USD |
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 271.015,50 USD |
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 340.928,40 USD |
| 28.09.2026 | 28.09.2026 | Doordash, Inc. | Prabir Adarkar | PRESIDENT AND COO | Verkauf | 292.445,24 USD |
| 28.09.2026 | 28.09.2026 | Royalty Pharma plc | Marshall Urist | EVP, Research & Investments | Verkauf | 238.812,88 USD |
| 28.09.2026 | 28.09.2026 | Blend Labs, Inc. | Nima Ghamsari | HEAD OF BLEND / Director | Verkauf | 24.820,35 USD |
| 28.09.2026 | 28.09.2026 | Billiontoone, Inc. | Oguzhan Atay | Chairman and CEO / Director | Verkauf | 321.626,24 USD |
| 28.09.2026 | 28.09.2026 | Billiontoone, Inc. | Oguzhan Atay | Chairman and CEO / Director | Verkauf | 1.005.293,12 USD |
| 28.09.2026 | 29.09.2026 | First Bancorp | Richard H. Moore | Chief Executive Officer / Director | Verkauf | 456.499,62 USD |
| 28.09.2026 | 28.09.2026 | First Bancorp | Richard H. Moore | Chief Executive Officer / Director | Verkauf | 1.010.672,00 USD |
| 28.09.2026 | 28.09.2026 | Aflac Inc. | Japan Post Holdings Co., Ltd. | 10% Owner | Verkauf | 18.280,00 USD |
| 28.09.2026 | 28.09.2026 | Aflac Inc. | Japan Post Holdings Co., Ltd. | 10% Owner | Verkauf | 1.345.260,80 USD |
| 28.09.2026 | 28.09.2026 | TCW Private Asset Income Fund 🔥 Cluster | Andrew Tarica | Director | Kauf | 12.862,50 USD |
| 28.09.2026 | 29.09.2026 | Fuller H B Co. 🔥 Cluster | Srilata Zaheer | Director | Kauf | 1.998,90 USD |
| 28.09.2026 | 28.09.2026 | Fuller H B Co. 🔥 Cluster | Srilata Zaheer | Director | Kauf | 98.120,00 USD |
| 28.09.2026 | 28.09.2026 | Fuller H B Co. 🔥 Cluster | Trangsrud Teresa J. Rasmussen | Director | Kauf | 24.490,00 USD |
| 28.09.2026 | 28.09.2026 | Fuller H B Co. 🔥 Cluster | Trangsrud Teresa J. Rasmussen | Director | Kauf | 75.494,32 USD |
| 28.09.2026 | 28.09.2026 | Fuller H B Co. 🔥 Cluster | Thomas W. Handley | Director | Kauf | 98.820,00 USD |
| 28.09.2026 | 28.09.2026 | Fuller H B Co. 🔥 Cluster | Daniel L. Florness | Director | Kauf | 100.160,20 USD |
| 28.09.2026 | 28.09.2026 | Nuveen Churchill Private Capital Income Fund | Kenneth J. Kencel | CEO and President | Kauf Class I | 249.999,99 USD |
| 28.09.2026 | 28.09.2026 | Nuveen Churchill Private Capital Income Fund | Kenneth J. Kencel | CEO and President | Kauf Class I | 249.999,99 USD |
| 28.09.2026 | 28.09.2026 | Culp Inc. | Robert George Culp IV | President & CEO / Director | Kauf | 11.514,40 USD |
| 28.09.2026 | 28.09.2026 | Nwpx Infrastructure, Inc. | Keith R. Larson | Director | Verkauf | 102.195,30 USD |
| 28.09.2026 | 28.09.2026 | Saul Centers, Inc. | Joel Albert Friedman | Exec VP, CAO & Treasurer | Kauf | 3.706,00 USD |
| 28.09.2026 | 29.09.2026 | Jewett Cameron Trading Co. Ltd. | AJB Investment Fund II, LP | 10% Owner | Kauf | 5.404,41 USD |
| 28.09.2026 | 29.09.2026 | Jewett Cameron Trading Co. Ltd. | AJB Investment Fund II, LP | 10% Owner | Kauf | 807,59 USD |
| 28.09.2026 | 28.09.2026 | Jewett Cameron Trading Co. Ltd. | AJB Investment Fund II, LP | 10% Owner | Kauf | 1.353,73 USD |
| 28.09.2026 | 29.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 124.134,21 USD |
| 28.09.2026 | 29.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 45.490,00 USD |
| 28.09.2026 | 29.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 851.110,70 USD |
| 28.09.2026 | 28.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 435.871,43 USD |
| 28.09.2026 | 28.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 247.807,14 USD |
| 28.09.2026 | 28.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 45.486,50 USD |
| 28.09.2026 | 28.09.2026 | Nayax Ltd. | Yair Nechmad | CEO, Co Founder & Chairman | Kauf | 357.680,00 USD |
| 28.09.2026 | 28.09.2026 | Prothena Corp. Public Ltd. Co. | William P. Scully | 10% Owner | Kauf | 889.872,30 USD |
| 28.09.2026 | 28.09.2026 | Gdev Inc. | Anton Reingold | See Remarks | Verkauf | 200.845,27 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 77.760,80 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 638.372,54 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 399.684,53 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 743.647,88 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 334.103,96 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 651.541,69 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 486.426,70 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 287.913,32 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 95.489,60 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 76.268,00 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 38.022,40 USD |
| 28.09.2026 | 28.09.2026 | United Therapeutics Corp. | Martine A. Rothblatt | Chairperson & CEO / Director | Verkauf | 322.629,47 USD |